Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	P-type calcium transporter activity	ATP2A1 ATP2A2 ATP2A3	3.58e-06	11	57	3	GO:0005388
GeneOntologyMolecularFunction	calcium-dependent ATPase activity	ATP2A1 ATP2A3	4.79e-05	4	57	2	GO:0030899
GeneOntologyMolecularFunction	P-type transmembrane transporter activity	ATP2A1 ATP2A2 ATP2A3	1.47e-04	36	57	3	GO:0140358
GeneOntologyMolecularFunction	P-type ion transporter activity	ATP2A1 ATP2A2 ATP2A3	1.47e-04	36	57	3	GO:0015662
GeneOntologyMolecularFunction	ATPase-coupled monoatomic cation transmembrane transporter activity	ATP2A1 ATP2A2 ATP2A3	7.40e-04	62	57	3	GO:0019829
GeneOntologyBiologicalProcess	calcium ion transport from cytosol to endoplasmic reticulum	ATP2A2 ATP2A3	7.24e-06	2	56	2	GO:1903515
GeneOntologyBiologicalProcess	positive regulation of endoplasmic reticulum calcium ion concentration	ATP2A1 ATP2A2	2.17e-05	3	56	2	GO:0032470
GeneOntologyBiologicalProcess	endoplasmic reticulum calcium ion homeostasis	ATP2A1 ATP2A2 ATP2A3	6.59e-05	29	56	3	GO:0032469
GeneOntologyBiologicalProcess	regulation of cardiac conduction	ATP2A1 ATP2A2 ATP2A3	6.59e-05	29	56	3	GO:1903779
GeneOntologyBiologicalProcess	cytosol to endoplasmic reticulum transport	ATP2A2 ATP2A3	7.20e-05	5	56	2	GO:0046967
GeneOntologyBiologicalProcess	calcium ion import into sarcoplasmic reticulum	ATP2A1 ATP2A2	1.51e-04	7	56	2	GO:1990036
GeneOntologyCellularComponent	platelet dense tubular network membrane	ATP2A1 ATP2A2 ATP2A3	1.96e-06	9	61	3	GO:0031095
GeneOntologyCellularComponent	platelet dense tubular network	ATP2A1 ATP2A2 ATP2A3	3.84e-06	11	61	3	GO:0031094
GeneOntologyCellularComponent	sarcoplasmic reticulum membrane	ATP2A1 ATP2A2 ATP2A3	3.07e-04	45	61	3	GO:0033017
GeneOntologyCellularComponent	postsynaptic density, intracellular component	DLGAP2 DLGAP1 SYNGAP1	3.96e-04	49	61	3	GO:0099092
GeneOntologyCellularComponent	postsynaptic specialization, intracellular component	DLGAP2 DLGAP1 SYNGAP1	5.87e-04	56	61	3	GO:0099091
GeneOntologyCellularComponent	postsynaptic specialization	DLGAP2 DLGAP1 NLGN2 PAK6 RTN1 CHRNB1 SYNGAP1	6.36e-04	503	61	7	GO:0099572
Domain	P-type_ATPase_IIA	ATP2A1 ATP2A2 ATP2A3	2.84e-08	3	58	3	IPR005782
Domain	Hydrolase_3	ATP2A1 ATP2A2 ATP2A3	3.36e-06	10	58	3	PF08282
Domain	NPIP	NPIPB13 NPIPB3 NPIPB5	1.01e-05	14	58	3	IPR009443
Domain	-	ATP2A1 ATP2A2 ATP2A3	1.55e-05	16	58	3	1.20.1110.10
Domain	ATPase_P-typ_TM_dom	ATP2A1 ATP2A2 ATP2A3	1.55e-05	16	58	3	IPR023298
Domain	ATPase_P-typ_cation-transptr_C	ATP2A1 ATP2A2 ATP2A3	1.87e-05	17	58	3	IPR006068
Domain	Cation_ATPase_C	ATP2A1 ATP2A2 ATP2A3	1.87e-05	17	58	3	PF00689
Domain	Cation_ATPase_N	ATP2A1 ATP2A2 ATP2A3	2.24e-05	18	58	3	PF00690
Domain	Cation_ATPase_N	ATP2A1 ATP2A2 ATP2A3	2.24e-05	18	58	3	SM00831
Domain	ATPase_P-typ_cation-transptr_N	ATP2A1 ATP2A2 ATP2A3	2.66e-05	19	58	3	IPR004014
Domain	FHA	FHAD1 TCF19 SLC4A1AP	8.81e-05	28	58	3	SM00240
Domain	-	PRPF3 RBM26	9.42e-05	5	58	2	1.20.1390.10
Domain	SAPAP	DLGAP2 DLGAP1	9.42e-05	5	58	2	IPR005026
Domain	GKAP	DLGAP2 DLGAP1	9.42e-05	5	58	2	PF03359
Domain	PWI	PRPF3 RBM26	9.42e-05	5	58	2	PF01480
Domain	PWI_dom	PRPF3 RBM26	9.42e-05	5	58	2	IPR002483
Domain	FHA_DOMAIN	FHAD1 TCF19 SLC4A1AP	1.20e-04	31	58	3	PS50006
Domain	FHA	FHAD1 TCF19 SLC4A1AP	1.20e-04	31	58	3	PF00498
Domain	-	ATP2A1 ATP2A2 ATP2A3	1.32e-04	32	58	3	3.40.1110.10
Domain	-	ATP2A1 ATP2A2 ATP2A3	1.32e-04	32	58	3	2.70.150.10
Domain	ATPase_P-typ_cyto_domN	ATP2A1 ATP2A2 ATP2A3	1.73e-04	35	58	3	IPR023299
Domain	FHA_dom	FHAD1 TCF19 SLC4A1AP	1.89e-04	36	58	3	IPR000253
Domain	P_typ_ATPase	ATP2A1 ATP2A2 ATP2A3	1.89e-04	36	58	3	IPR001757
Domain	ATPase_P-typ_P_site	ATP2A1 ATP2A2 ATP2A3	1.89e-04	36	58	3	IPR018303
Domain	ATPASE_E1_E2	ATP2A1 ATP2A2 ATP2A3	1.89e-04	36	58	3	PS00154
Domain	-	FHAD1 TCF19 SLC4A1AP	1.89e-04	36	58	3	2.60.200.20
Domain	WASP_C	WASL PAK6	1.97e-04	7	58	2	IPR011026
Domain	ATPase_P-typ_transduc_dom_A	ATP2A1 ATP2A2 ATP2A3	2.05e-04	37	58	3	IPR008250
Domain	E1-E2_ATPase	ATP2A1 ATP2A2 ATP2A3	2.05e-04	37	58	3	PF00122
Domain	SMAD_FHA_domain	FHAD1 TCF19 SLC4A1AP	5.64e-04	52	58	3	IPR008984
Domain	PBD	WASL PAK6	1.11e-03	16	58	2	SM00285
Domain	PBD	WASL PAK6	1.25e-03	17	58	2	PF00786
Domain	CRIB	WASL PAK6	1.74e-03	20	58	2	PS50108
Domain	HAD-like_dom	ATP2A1 ATP2A2 ATP2A3	1.90e-03	79	58	3	IPR023214
Domain	CRIB_dom	WASL PAK6	1.92e-03	21	58	2	IPR000095
Domain	Rho_GTPase_activation_prot	FAM13A ARAP1 SYNGAP1	2.59e-03	88	58	3	IPR008936
Domain	Bromodomain_CS	BRD4 SMARCA4	2.94e-03	26	58	2	IPR018359
Domain	AT_hook	KMT2B AHDC1	3.16e-03	27	58	2	SM00384
Domain	AT_hook_DNA-bd_motif	KMT2B AHDC1	3.16e-03	27	58	2	IPR017956
Domain	BROMODOMAIN_1	BRD4 SMARCA4	5.89e-03	37	58	2	PS00633
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA	ATP2A1 ATP2A2 ATP2A3	1.27e-06	8	41	3	M47955
Pathway	REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS	ATP2A1 ATP2A2 ATP2A3	4.93e-06	12	41	3	M27326
Pathway	REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS	ATP2A1 ATP2A2 ATP2A3	8.13e-06	14	41	3	MM15052
Pathway	REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI	ATP2A1 ATP2A2 ATP2A3	1.81e-05	18	41	3	M614
Pathway	REACTOME_PLATELET_CALCIUM_HOMEOSTASIS	ATP2A1 ATP2A2 ATP2A3	6.36e-05	27	41	3	MM15053
Pathway	REACTOME_PLATELET_CALCIUM_HOMEOSTASIS	ATP2A1 ATP2A2 ATP2A3	7.11e-05	28	41	3	M924
Pathway	REACTOME_NEUREXINS_AND_NEUROLIGINS	DLGAP2 DLGAP1 NLGN2	1.07e-04	32	41	3	MM15326
Pathway	WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV	DLGAP1 NLGN2 SYNGAP1	1.17e-04	33	41	3	M39875
Pathway	REACTOME_ION_HOMEOSTASIS	ATP2A1 ATP2A2 ATP2A3	5.11e-04	54	41	3	M27460
Pathway	REACTOME_ION_HOMEOSTASIS	ATP2A1 ATP2A2 ATP2A3	5.11e-04	54	41	3	MM15202
Pathway	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES	ATP2A1 ATP2A2 ATP2A3	5.39e-04	55	41	3	M971
Pathway	REACTOME_NEUREXINS_AND_NEUROLIGINS	DLGAP2 DLGAP1 NLGN2	5.69e-04	56	41	3	M27616
Pathway	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES	ATP2A1 ATP2A2 ATP2A3	5.99e-04	57	41	3	MM15643
Pathway	REACTOME_RHOA_GTPASE_CYCLE	LMAN1 FAM13A RTKN ARAP1	7.48e-04	142	41	4	MM15576
Pathway	REACTOME_RHOA_GTPASE_CYCLE	LMAN1 FAM13A RTKN ARAP1	8.96e-04	149	41	4	M41805
Pathway	REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES	DLGAP2 DLGAP1 NLGN2	9.61e-04	67	41	3	MM15327
Pathway	WP_ALZHEIMERS_DISEASE	ATP2A1 ATP2A2 ATP2A3	1.28e-03	74	41	3	MM15962
Pathway	REACTOME_PLATELET_HOMEOSTASIS	ATP2A1 ATP2A2 ATP2A3	1.39e-03	76	41	3	MM15051
Pubmed	The effects of the phenylalanine 256 to valine mutation on the sensitivity of sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) Ca2+ pump isoforms 1, 2, and 3 to thapsigargin and other inhibitors.	ATP2A1 ATP2A2 ATP2A3	5.66e-09	3	63	3	16410239
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	GSTZ1 DLGAP2 DLGAP1 WASL KMT2B BRD4 SH3KBP1 MAP2K5 ATP2A3	8.22e-09	329	63	9	17474147
Pubmed	The nongastric H+-K+-ATPases: molecular and functional properties.	ATP2A1 ATP2A2 ATP2A3	2.26e-08	4	63	3	10362770
Pubmed	Expression of sarco (endo) plasmic reticulum calcium ATPase (SERCA) system in normal mouse cardiovascular tissues, heart failure and atherosclerosis.	ATP2A1 ATP2A2 ATP2A3	2.26e-08	4	63	3	25110346
Pubmed	Learning and reaction times in mouse touchscreen tests are differentially impacted by mutations in genes encoding postsynaptic interacting proteins SYNGAP1, NLGN3, DLGAP1, DLGAP2 and SHANK2.	DLGAP2 DLGAP1 SYNGAP1	5.65e-08	5	63	3	33347690
Pubmed	Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1.	ATP2A1 ATP2A2 ATP2A3	1.97e-07	7	63	3	24786561
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	DLGAP1 SH3KBP1 FMN2 NLGN2 LMTK3 ATP2A2 RTN1 SYNGAP1	2.18e-07	347	63	8	17114649
Pubmed	Gene knockout studies of Ca2+-transporting ATPases.	ATP2A1 ATP2A2 ATP2A3	3.15e-07	8	63	3	10951186
Pubmed	Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death.	ATP2A1 ATP2A2 ATP2A3	3.15e-07	8	63	3	19033399
Pubmed	Widespread control of calcium signaling by a family of SERCA-inhibiting micropeptides.	ATP2A1 ATP2A2 ATP2A3	3.15e-07	8	63	3	27923914
Pubmed	ARAP1 association with CIN85 affects epidermal growth factor receptor endocytic trafficking.	INPP5D SH3KBP1 ARAP1	4.72e-07	9	63	3	21275903
Pubmed	A micropeptide encoded by a putative long noncoding RNA regulates muscle performance.	ATP2A1 ATP2A2 ATP2A3	4.72e-07	9	63	3	25640239
Pubmed	Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.	DLGAP2 DLGAP1 SH3KBP1 NLGN2 PAK6 SYNGAP1	1.59e-06	197	63	6	36604605
Pubmed	Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks.	DLGAP2 DLGAP1 WASL SH3KBP1 AHDC1	1.83e-06	111	63	5	22558309
Pubmed	CIN85 interacting proteins in B cells-specific role for SHIP-1.	WASL INPP5D SH3KBP1 ARAP1	2.89e-06	54	63	4	21725061
Pubmed	Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.	WASL SLC4A1AP PRPF3 SMARCA4 SRPK1 ATP2A1	3.01e-06	220	63	6	24550385
Pubmed	Targeted disruption of the ATP2A1 gene encoding the sarco(endo)plasmic reticulum Ca2+ ATPase isoform 1 (SERCA1) impairs diaphragm function and is lethal in neonatal mice.	ATP2A1 ATP2A2	3.23e-06	2	63	2	12556521
Pubmed	Regulation of SERCA pumps expression in diabetes.	ATP2A2 ATP2A3	3.23e-06	2	63	2	25270119
Pubmed	Atypical fast SERCA1a protein expression in slow myofibers and differential S-nitrosylation prevented by exercise during long term bed rest.	ATP2A1 ATP2A2	3.23e-06	2	63	2	19644701
Pubmed	Sarco(endo)plasmic reticulum Ca2+ ATPases (SERCA1 and -2) in human extraocular muscles.	ATP2A1 ATP2A2	3.23e-06	2	63	2	14638697
Pubmed	SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4.	BRD4 SRPK1	3.23e-06	2	63	2	30568163
Pubmed	Sarco(endo)plasmic reticulum Ca2+ ATPase isoforms and their role in muscle physiology and pathology.	ATP2A1 ATP2A2	3.23e-06	2	63	2	10603953
Pubmed	Essential role of BRG, the ATPase subunit of BAF chromatin remodeling complexes, in leukemia maintenance.	PTPRC SMARCA4	3.23e-06	2	63	2	24478402
Pubmed	Characterizing SERCA Function in Murine Skeletal Muscles after 35-37 Days of Spaceflight.	ATP2A1 ATP2A2	3.23e-06	2	63	2	34769190
Pubmed	Alterations in genes encoding sarcoplasmic-endoplasmic reticulum Ca(2+) pumps in association with head and neck squamous cell carcinoma.	ATP2A2 ATP2A3	3.23e-06	2	63	2	18295663
Pubmed	Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein-Barr virus latent membrane protein-1.	ATP2A2 ATP2A3	3.23e-06	2	63	2	19650915
Pubmed	Training induced decrease in oxygen cost of cycling is accompanied by down-regulation of SERCA expression in human vastus lateralis muscle.	ATP2A1 ATP2A2	3.23e-06	2	63	2	18953100
Pubmed	SERCA overexpression reduces hydroxyl radical injury in murine myocardium.	ATP2A1 ATP2A2	3.23e-06	2	63	2	16798816
Pubmed	Mechanisms of control of the free Ca2+ concentration in the endoplasmic reticulum of mouse pancreatic β-cells: interplay with cell metabolism and [Ca2+]c and role of SERCA2b and SERCA3.	ATP2A2 ATP2A3	3.23e-06	2	63	2	21885870
Pubmed	Multiple and diverse coexpression, location, and regulation of additional SERCA2 and SERCA3 isoforms in nonfailing and failing human heart.	ATP2A2 ATP2A3	3.23e-06	2	63	2	19962989
Pubmed	Dissection of the functional differences between sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) 1 and 2 isoforms and characterization of Darier disease (SERCA2) mutants by steady-state and transient kinetic analyses.	ATP2A1 ATP2A2	3.23e-06	2	63	2	12975374
Pubmed	Effect of chronic obstructive pulmonary disease on calcium pump ATPase expression in human diaphragm.	ATP2A1 ATP2A2	3.23e-06	2	63	2	15718407
Pubmed	SERCA1 truncated proteins unable to pump calcium reduce the endoplasmic reticulum calcium concentration and induce apoptosis.	ATP2A1 ATP2A2	3.23e-06	2	63	2	11402072
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	FLII WASL KMT2B SLC4A1AP PRPF3 BRD4 SMARCA4 FMN2	3.65e-06	506	63	8	30890647
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	KMT2B SLC4A1AP PRPF3 RBM26 SMARCA4 SRPK1	6.41e-06	251	63	6	31076518
Pubmed	The ER-Localized Transmembrane Protein EPG-3/VMP1 Regulates SERCA Activity to Control ER-Isolation Membrane Contacts for Autophagosome Formation.	ATP2A1 ATP2A2 ATP2A3	8.51e-06	22	63	3	28890335
Pubmed	Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle.	ATP2A1 ATP2A2	9.68e-06	3	63	2	27055500
Pubmed	Sarcoplasmic reticulum Ca2+ ATPase pump is a major regulator of glucose transport in the healthy and diabetic heart.	ATP2A1 ATP2A2	9.68e-06	3	63	2	25615793
Pubmed	Modulation of endoplasmic reticulum calcium pump by Bcl-2.	ATP2A2 ATP2A3	9.68e-06	3	63	2	9788433
Pubmed	Human platelet Ca2+-ATPases: new markers of cell differentiation as illustrated in idiopathic scoliosis.	ATP2A2 ATP2A3	9.68e-06	3	63	2	16973504
Pubmed	Alteration of RANKL-induced osteoclastogenesis in primary cultured osteoclasts from SERCA2+/- mice.	ATP2A2 ATP2A3	9.68e-06	3	63	2	19419309
Pubmed	Phospholamban domain IB forms an interaction site with the loop between transmembrane helices M6 and M7 of sarco(endo)plasmic reticulum Ca2+ ATPases.	ATP2A1 ATP2A2	9.68e-06	3	63	2	11526231
Pubmed	LncRNA ARAP1-AS2 promotes high glucose-induced human proximal tubular cell injury via persistent transactivation of the EGFR by interacting with ARAP1.	SH3KBP1 ARAP1	9.68e-06	3	63	2	32969198
Pubmed	Islet secretory defect in insulin receptor substrate 1 null mice is linked with reduced calcium signaling and expression of sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA)-2b and -3.	ATP2A2 ATP2A3	9.68e-06	3	63	2	15161756
Pubmed	Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1.	ATP2A1 ATP2A2	9.68e-06	3	63	2	15972723
Pubmed	Epigenetic mechanisms modulate thyroid transcription factor 1-mediated transcription of the surfactant protein B gene.	SFTPB SMARCA4	9.68e-06	3	63	2	19906647
Pubmed	Divergent origins and concerted expansion of two segmental duplications on chromosome 16.	NPIPB3 NPIPB5	9.68e-06	3	63	2	11948212
Pubmed	Biochemical and Structural Studies of the Interaction between ARAP1 and CIN85.	SH3KBP1 ARAP1	9.68e-06	3	63	2	29589748
Pubmed	Relevance of brain natriuretic peptide in preload-dependent regulation of cardiac sarcoplasmic reticulum Ca2+ ATPase expression.	ATP2A1 ATP2A2	9.68e-06	3	63	2	16754798
Pubmed	Coordinate regulation of SR Ca(2+)-ATPase and phospholamban expression in developing murine heart.	ATP2A1 ATP2A2	9.68e-06	3	63	2	9038922
Pubmed	Specific effects of endurance and sprint training on protein expression of calsequestrin and SERCA in mouse skeletal muscle.	ATP2A1 ATP2A2	9.68e-06	3	63	2	22466636
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	UBR1 FLII PTPRC KMT2B FAM13A SLC4A1AP BRD4 SMARCA4 ATP2A2	1.03e-05	774	63	9	15302935
Pubmed	Immune cell inhibition by SLAMF7 is mediated by a mechanism requiring src kinases, CD45, and SHIP-1 that is defective in multiple myeloma cells.	PTPRC INPP5D	1.93e-05	4	63	2	25312647
Pubmed	Brd4's Bromodomains Mediate Histone H3 Acetylation and Chromatin Remodeling in Pluripotent Cells through P300 and Brg1.	BRD4 SMARCA4	1.93e-05	4	63	2	30428346
Pubmed	High-resolution mapping and transcript identification at the progressive epilepsy with mental retardation locus on chromosome 8p.	DLGAP2 FAM13A	1.93e-05	4	63	2	9314494
Pubmed	Sarcolipin inhibits polymerization of phospholamban to induce superinhibition of sarco(endo)plasmic reticulum Ca2+-ATPases (SERCAs).	ATP2A1 ATP2A2	1.93e-05	4	63	2	12032137
Pubmed	CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis.	PTPRC INPP5D	1.93e-05	4	63	2	10229804
Pubmed	Lack of nitric oxide synthase depresses ion transporting enzyme function in cardiac muscle.	ATP2A1 ATP2A2	1.93e-05	4	63	2	12074580
Pubmed	Insulin receptor substrate proteins create a link between the tyrosine phosphorylation cascade and the Ca2+-ATPases in muscle and heart.	ATP2A1 ATP2A2	1.93e-05	4	63	2	9295312
Pubmed	SERCA1a can functionally substitute for SERCA2a in the heart.	ATP2A1 ATP2A2	1.93e-05	4	63	2	9887021
Pubmed	Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy.	ATP2A1 ATP2A2	1.93e-05	4	63	2	10555147
Pubmed	SERCA2b and 3 play a regulatory role in store-operated calcium entry in human platelets.	ATP2A2 ATP2A3	1.93e-05	4	63	2	18068335
Pubmed	Biology, structure and mechanism of P-type ATPases.	ATP2A1 ATP2A2 ATP2A3	2.00e-05	29	63	3	15071553
Pubmed	Centronuclear myopathy in mice lacking a novel muscle-specific protein kinase transcriptionally regulated by MEF2.	SRPK1 ATP2A1 ATP2A2	2.46e-05	31	63	3	16140986
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ACSL1 KMT2B LMAN1 PRPF3 INPP5D BRD4 RBM26 SMARCA4 ATP2A2 AHDC1	2.75e-05	1103	63	10	34189442
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FLII KMT2B ZNF827 BRD4 NLGN2 MBD5 ATP2A3 LYST AHDC1 ARAP1	2.79e-05	1105	63	10	35748872
Pubmed	Functional impact of global rare copy number variation in autism spectrum disorders.	DLGAP2 SYNGAP1	3.22e-05	5	63	2	20531469
Pubmed	Differential mRNA expression and protein localization of the SAP90/PSD-95-associated proteins (SAPAPs) in the nervous system of the mouse.	DLGAP2 DLGAP1	3.22e-05	5	63	2	15024750
Pubmed	The DWORF micropeptide enhances contractility and prevents heart failure in a mouse model of dilated cardiomyopathy.	ATP2A1 ATP2A2	3.22e-05	5	63	2	30299255
Pubmed	N-wasp is essential for the negative regulation of B cell receptor signaling.	WASL INPP5D	3.22e-05	5	63	2	24223520
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	ATP2A1 ATP2A2 ATP2A3	4.57e-05	38	63	3	30786075
Pubmed	Patients and mice with deficiency in the SNARE protein SYNTAXIN-11 have a secondary B cell defect.	PTPRC LYST	4.82e-05	6	63	2	38722309
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	FLII DLGAP2 DLGAP1 SH3KBP1 SMARCA4 NLGN2 LMTK3 RTN1 SYNGAP1	5.71e-05	963	63	9	28671696
Pubmed	Comparative Protein Interaction Network Analysis Identifies Shared and Distinct Functions for the Human ROCO Proteins.	SLC4A1AP TGIF2LX PAK6 RTKN AHDC1	6.23e-05	230	63	5	29513927
Pubmed	SAPAPs. A family of PSD-95/SAP90-associated proteins localized at postsynaptic density.	DLGAP2 DLGAP1	6.74e-05	7	63	2	9115257
Pubmed	Proline-rich synapse-associated proteins ProSAP1 and ProSAP2 interact with synaptic proteins of the SAPAP/GKAP family.	DLGAP2 DLGAP1	6.74e-05	7	63	2	10527873
Pubmed	DAP-1, a novel protein that interacts with the guanylate kinase-like domains of hDLG and PSD-95.	DLGAP2 DLGAP1	6.74e-05	7	63	2	9286858
Pubmed	The inositol phosphatase SHIP-1 inhibits NOD2-induced NF-κB activation by disturbing the interaction of XIAP with RIP2.	INPP5D SH3KBP1	8.98e-05	8	63	2	22815893
Pubmed	Fragile X mental retardation protein regulates the levels of scaffold proteins and glutamate receptors in postsynaptic densities.	DLGAP2 DLGAP1	8.98e-05	8	63	2	19640847
Pubmed	SERCA pump activity is physiologically regulated by presenilin and regulates amyloid beta production.	ATP2A2 CHRNB1	8.98e-05	8	63	2	18591429
Pubmed	Paracrine effect of regulatory T cells promotes cardiomyocyte proliferation during pregnancy and after myocardial infarction.	PTPRC LYST	8.98e-05	8	63	2	29946151
Pubmed	Orphan G protein-coupled receptor GPR116 regulates pulmonary surfactant pool size.	PTPRC SFTPB	8.98e-05	8	63	2	23590306
Pubmed	Early Developmental Disruption of Type 2 Deiodinase Pathway in Mouse Skeletal Muscle Does Not Impair Muscle Function.	ATP2A1 ATP2A2	8.98e-05	8	63	2	27967605
Pubmed	Sequential docking, molecular differentiation, and positioning of T-Tubule/SR junctions in developing mouse skeletal muscle.	ATP2A1 ATP2A2	8.98e-05	8	63	2	11784029
Pubmed	KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4.	FLII PRPF3 BRD4 RBM26	9.36e-05	130	63	4	35545047
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	DLGAP2 DLGAP1 SH3KBP1 NLGN2 SYNGAP1	9.40e-05	251	63	5	27507650
Pubmed	Mechanisms and Consequences of Dopamine Depletion-Induced Attenuation of the Spinophilin/Neurofilament Medium Interaction.	DLGAP2 DLGAP1 ATP2A2 SYNGAP1	9.64e-05	131	63	4	28634551
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	KMT2B PRPF3 BRD4 SMARCA4	1.05e-04	134	63	4	25452129
Pubmed	The P4-type ATPase ATP11C is essential for B lymphopoiesis in adult bone marrow.	PTPRC INPP5D	1.15e-04	9	63	2	21423172
Pubmed	The Na(+)-K(+)-ATPase alpha2-subunit isoform modulates contractility in the perinatal mouse diaphragm.	ATP2A1 ATP2A2	1.15e-04	9	63	2	15253893
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	PRPF3 BRD4 RBM26 SMARCA4 AHDC1	1.28e-04	268	63	5	33640491
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	FLII PRPF3 GLDC SMARCA4 SRPK1	1.42e-04	274	63	5	34244482
Pubmed	Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc.	MYCLP1 TYMP	1.44e-04	10	63	2	10229200
Pubmed	The Polycomb-group gene Rae28 sustains Nkx2.5/Csx expression and is essential for cardiac morphogenesis.	ATP2A1 ATP2A2	1.76e-04	11	63	2	12122109
Pubmed	CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptors.	INPP5D SH3KBP1	1.76e-04	11	63	2	15090612
Pubmed	Prediction of the coding sequences of unidentified human genes. XXI. The complete sequences of 60 new cDNA clones from brain which code for large proteins.	FHAD1 LMTK3 SYNGAP1	2.08e-04	63	63	3	11572484
Pubmed	A missense mutation in the previously undescribed gene Tmhs underlies deafness in hurry-scurry (hscy) mice.	SLC26A8 SRPK1	2.11e-04	12	63	2	15905332
Pubmed	IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms.	PTPRC INPP5D	2.11e-04	12	63	2	26011644
Pubmed	Distinct Distribution of RTN1A in Immune Cells in Mouse Skin and Lymphoid Organs.	PTPRC RTN1	2.49e-04	13	63	2	33542915
Pubmed	FBXO42 facilitates Notch signaling activation and global chromatin relaxation by promoting K63-linked polyubiquitination of RBPJ.	FLII KMT2B SMARCA4 ATP2A2	3.47e-04	183	63	4	36129980
Interaction	DDN interactions	DLGAP1 SH3KBP1 SYNGAP1	2.97e-06	10	60	3	int:DDN
Cytoband	16p12.2	NPIPB4 NPIPB3 NPIPB5	1.85e-05	37	63	3	16p12.2
Cytoband	Ensembl 112 genes in cytogenetic band chr16p11	NPIPB13 NPIPB12 NPIPB11 ATP2A1	5.92e-04	278	63	4	chr16p11
Cytoband	Ensembl 112 genes in cytogenetic band chr16p12	NPIPB4 NPIPB3 NPIPB5	1.74e-03	172	63	3	chr16p12
Cytoband	16p11.2	NPIPB13 NPIPB12 NPIPB11	2.34e-03	191	63	3	16p11.2
GeneFamily	ATPases Ca2+ transporting	ATP2A1 ATP2A2 ATP2A3	4.62e-07	9	33	3	1209
Coexpression	YOSHIMURA_MAPK8_TARGETS_UP	DLGAP2 DLGAP1 PTPRC SFTPB INPP5D SH3KBP1 NLGN2 CHORDC1 MAP2K5 ATP2A3 RTN1 CHRNB1 SYNGAP1	9.11e-06	1281	63	13	M1884
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL1 PTPRC INPP5D SH3KBP1 ATP2A3 RTN1	2.83e-07	189	63	6	7ccea2df93bb4b37417bbc8f6c85a61ece95211a
ToppCell	COVID-19-Myeloid-Dendritic_cells\|COVID-19 / group, cell type (main and fine annotations)	ACSL1 PTPRC INPP5D TYMP RTN1	2.81e-06	156	63	5	a07a9096799e4ba663841c70035b4b32c1fda4f9
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRG3 RBM26 CCDC89 ATP2A2 ATP2A3	3.81e-06	166	63	5	66026988509e39e41274fa0de738383219e8ff30
ToppCell	Control-Myeloid-Monocytes\|Control / group, cell type (main and fine annotations)	ACSL1 PTPRC INPP5D LYST RTN1	7.16e-06	189	63	5	3335d16bd0ffa0c1ddd06d7da645299148130c3f
ToppCell	Control-Myeloid-Transitioning_MDM\|Control / group, cell type (main and fine annotations)	ACSL1 PTPRC INPP5D TYMP RTN1	7.34e-06	190	63	5	d6fd8c23cde4a10cc1517b6899a5a855fdfff2e2
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL1 PTPRC INPP5D SH3KBP1 RTN1	7.53e-06	191	63	5	468b5149d1533f03521844d3cce8633d44eb6ed4
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL1 PTPRC SH3KBP1 TYMP RTN1	7.53e-06	191	63	5	47a2afc4102199b4bc76bd01b2967c8016186462
ToppCell	RA-08._Macrophage\|World / Chamber and Cluster_Paper	ACSL1 PTPRC INPP5D TYMP RTN1	7.92e-06	193	63	5	5fd22db1825d105709fcc0aa4955c99a117e3c82
ToppCell	nucseq-Immune-Immune_Myeloid-pMON-pMON\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PTPRC INPP5D TYMP LYST ARAP1	8.12e-06	194	63	5	e237384b02be460d44eeada3026a5691c66f6fc1
ToppCell	nucseq-Immune-Immune_Myeloid-pMON\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PTPRC INPP5D TYMP LYST ARAP1	8.12e-06	194	63	5	0bc83ae79873a5e473e6e1e3111924cd003986a1
ToppCell	RA-08._Macrophage\|RA / Chamber and Cluster_Paper	ACSL1 PTPRC INPP5D TYMP RTN1	8.12e-06	194	63	5	ac26e5c71d5069622de72fa25a9c920887ac2c19
ToppCell	Adult-Immune-monocyte-D231\|Adult / Lineage, Cell type, age group and donor	PTPRC INPP5D TYMP LYST RTN1	8.33e-06	195	63	5	ea24da6fea1487acb1e56c28c0649858cc0a12bd
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL1 PTPRC INPP5D TYMP RTN1	8.75e-06	197	63	5	8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5
ToppCell	Fetal_29-31_weeks-Immune-monocyte\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ACSL1 PTPRC INPP5D TYMP RTN1	8.75e-06	197	63	5	48a8169a4d33c6a68d66bcd936861c75cb4b60ef
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC INPP5D SH3KBP1 TYMP RTN1	8.75e-06	197	63	5	c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL1 PTPRC SH3KBP1 TYMP RTN1	8.75e-06	197	63	5	1eb9ff8467118b943b5d443cb996168e1e1206b5
ToppCell	COVID-19-lung-Macrophage_VCANhi_FCN1hi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ACSL1 PTPRC INPP5D TYMP ARAP1	8.97e-06	198	63	5	ea34096bee852a7e996f097fa279381afa8f86ff
ToppCell	Immune\|World / Lineage, Cell type, age group and donor	ACSL1 PTPRC INPP5D TYMP RTN1	8.97e-06	198	63	5	65681b54d13c6997bd90a1c2a12314a80e964fe3
ToppCell	COVID-19-lung\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PTPRC SFTPB SH3KBP1 TYMP ARAP1	9.19e-06	199	63	5	155b03b859157013e9142e9248551369127d9204
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PTPRC INPP5D TYMP LYST RTN1	9.41e-06	200	63	5	fc061de0db2e8b5ca47f5e2a1e861018e7f1b582
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DLGAP2 TCF19 FMN2 CHRNB1	3.27e-05	128	63	4	2cf0384240a4a663869cf6b27d954236f6214a9a
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRC FMN2 LYST RTN1	5.91e-05	149	63	4	48fca6ae33d7722c024b43ce04f4dbce7b6b424b
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-myeloid_leukocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRC FMN2 LYST RTN1	6.39e-05	152	63	4	7e686721b95c837f2b0d5116927c8ecacef055ee
ToppCell	facs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l26\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADGRG3 INPP5D DCLK3 ATP2A3	7.06e-05	156	63	4	da5cfa8fa9595613f04ce9511f8b42bad34d995a
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ACSL1 NPIPB13 NPIPB11 SEC31B	8.37e-05	163	63	4	4be3158f2a0ab460cfea8080a7370922910b5da9
ToppCell	facs-Trachea-nan-18m-Myeloid-granulocyte\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRG3 PTPRC INPP5D DCLK3	8.98e-05	166	63	4	7f8b4cf63c3e292ae421f111edaa4572717f4db1
ToppCell	facs-Skin-Skin_Anagen-18m-Lymphocytic-T_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRG3 PTPRC INPP5D LMTK3	9.63e-05	169	63	4	630d921aa8fb5681d06a4e09b833855c374be484
ToppCell	facs-Skin-Skin_Anagen-18m-Lymphocytic-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRG3 PTPRC INPP5D LMTK3	9.63e-05	169	63	4	468284d4a3a0557aed04eadb1aba2317babc6904
ToppCell	facs-Skin-Skin_Anagen-18m-Lymphocytic\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRG3 PTPRC INPP5D LMTK3	9.63e-05	169	63	4	6f765e142d127545e622fe24b5287cd6e9706ccc
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Lymphocytic\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRG3 PTPRC CFAP77 SFTPB	1.03e-04	172	63	4	3ffe721f62c0d20c1d765ecb15ed4e1aa88099f7
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Lymphocytic-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRG3 PTPRC CFAP77 SFTPB	1.03e-04	172	63	4	2bbe3f601a56577d200aa7ba7031f7c19b988cc1
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Lymphocytic-T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRG3 PTPRC CFAP77 SFTPB	1.05e-04	173	63	4	7c5e4809205ce1a0a301c15442af00a2e2b9b301
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	BHLHE41 LMAN1 GLDC LMTK3	1.08e-04	174	63	4	bdbaf805a94b2f5a0065933dab6bf84e3cabd525
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	BHLHE41 TCF19 LMAN1 GLDC	1.10e-04	175	63	4	3b5346fba617292de71963b6175e85a4f182fe30
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP2 ADGRG3 NPIPB12 TDRD10	1.10e-04	175	63	4	9a96a946db731ba24c9be34bedebf1f4a1372b9e
ToppCell	droplet-Kidney-KIDNEY-30m-Mesenchymal-podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRG3 SFTPB RTKN RTN1	1.10e-04	175	63	4	31f0fb2e47e357dbf9c15436b7df85b3c370ded7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP2 ADGRG3 NPIPB12 TDRD10	1.10e-04	175	63	4	54c1f080195ad8392a095e83b56a4b54073d4c0d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP2 ADGRG3 NPIPB12 TDRD10	1.10e-04	175	63	4	2b51406a2c2daa13ab4ed283ede038cd11d9e641
ToppCell	facs-Trachea-24m-Hematologic-lymphocytic-B_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BHLHE41 INPP5D RBM26 ATP2A3	1.13e-04	176	63	4	318dc722b95e269002fb01a0feb91c0c8539e150
ToppCell	facs-Trachea-24m-Hematologic-lymphocytic-B_cell-B_cell_of_the_trachea\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BHLHE41 INPP5D RBM26 ATP2A3	1.13e-04	176	63	4	f6891006d816309edabe75b2abf60675f2958e55
ToppCell	CV-Severe-7\|CV / Virus stimulation, Condition and Cluster	PTPRC NPIPB3 NPIPB5 LYST	1.13e-04	176	63	4	3de0c7d77210049e5616db21eed1490a17a5ec2d
ToppCell	Dendritic_Cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	INPP5D DCLK3 NPIPB3 RTN1	1.15e-04	177	63	4	d2cd081bdda0eba9f6f6473c4d3939e4bee3440e
ToppCell	CV-Severe-7\|Severe / Virus stimulation, Condition and Cluster	PTPRC NPIPB3 NPIPB5 LYST	1.15e-04	177	63	4	82fdd6185b368f54f03de389427cbe3071d21a99
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADGRG3 PTPRC GLDC LYST	1.25e-04	181	63	4	71e55acd1d8e4307e56534c74a50e7be4d1dda0d
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-CD8_TRM\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PTPRC NPIPB4 NPIPB11 SEC31B	1.34e-04	184	63	4	17ffa0e890960c00a3b5fa33d48caba66c61dbb0
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BHLHE41 ACSL1 PTPRC ATP2A1	1.34e-04	184	63	4	840fac463665ed18752f402f7d1ef2e5052bdf74
ToppCell	wk_08-11-Epithelial-PNS-PCP4+_neuron\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	DLGAP1 DCLK3 FMN2 RTN1	1.34e-04	184	63	4	eac2a9089913f33a961ba11519b53645790f2056
ToppCell	18-Distal-Epithelial-Neuroendocrine\|Distal / Age, Tissue, Lineage and Cell class	ACSL1 DLGAP2 ATP2A3 RTN1	1.36e-04	185	63	4	f8fc7b12b4e18d23d84e95488be93c4352d325f3
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-Plasma_cells-IgM_plasma_cell\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BHLHE41 LMAN1 SFTPB LMTK3	1.39e-04	186	63	4	a67e818c5ab682c2058fccc85f3fade0e11cb56e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC INPP5D SH3KBP1 RTN1	1.39e-04	186	63	4	e152bdd837366e3e0b8bcfdb4d53f0685f2e803a
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADGRG3 PTPRC INPP5D ATP2A3	1.42e-04	187	63	4	42b20d7f0a4f9195b3d71dc0e089b5e0914ebcbb
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	PTPRC NPIPB4 FAM13A CHORDC1	1.45e-04	188	63	4	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	wk_08-11-Hematologic-Myeloid-Promonocyte-like\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	ADGRG3 PTPRC INPP5D TYMP	1.45e-04	188	63	4	2ae945d96a011f246d04a42bcd6ef443232b03f4
ToppCell	Tracheal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ADGRG3 PTPRC INPP5D ATP2A1	1.45e-04	188	63	4	a3ab4ebed658c4b044ab72eea668e6b10086801f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC INPP5D LYST RTN1	1.45e-04	188	63	4	4e27ada1bda88811b73376c8a6136cbfc83bfdb9
ToppCell	Fetal_29-31_weeks-Immune-natural_killer_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADGRG3 PTPRC INPP5D LYST	1.45e-04	188	63	4	6686dbba990066568aa7573e70a7db8b4758f457
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL1 PTPRC INPP5D RTN1	1.45e-04	188	63	4	0d7296ad26e97ad91c6927a6cfe4e6e70a74c5a6
ToppCell	Bac-SEP-Lymphocyte-B-Plasmablast\|Bac-SEP / Disease, Lineage and Cell Type	BHLHE41 TCF19 LMAN1 GLDC	1.48e-04	189	63	4	6339b6d1056e07cefb0e1b2a0e479913c5783c8a
ToppCell	COPD\|World / Disease state, Lineage and Cell class	PTPRC NPIPB4 INPP5D NPIPB3	1.48e-04	189	63	4	53577632683686dc493a5a3fdc01887ec5c320f2
ToppCell	Adult\|World / Lineage, Cell type, age group and donor	ACSL1 SFTPB TYMP ARAP1	1.48e-04	189	63	4	5cd285bfad973125d46d704fec18b21266a63379
ToppCell	COVID-19-Heart-Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ACSL1 PTPRC INPP5D RTN1	1.48e-04	189	63	4	2586f4088721c5debec86c2b211b739fd33713eb
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL1 PTPRC INPP5D RTN1	1.51e-04	190	63	4	7c402aa47f1bd7decacc366c1ed1a37e39b95c73
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC INPP5D SH3KBP1 ATP2A3	1.51e-04	190	63	4	07ea0578ca0561077557203ae660530f53fc4067
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC INPP5D SH3KBP1 ATP2A3	1.51e-04	190	63	4	b772a5d281fe016f259ddda80d6f33d949dcac2b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC INPP5D SH3KBP1 ATP2A3	1.51e-04	190	63	4	5b4b3eed7aa798bb7e3c5e968c8dc4144e377a5f
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC INPP5D SH3KBP1 RTN1	1.54e-04	191	63	4	51f5af610983aa73b9f4ece6f27d281ebff89a04
ToppCell	COVID-19-kidney-T-cells-2\|kidney / Disease (COVID-19 only), tissue and cell type	PTPRC INPP5D CHORDC1 ATP2A3	1.54e-04	191	63	4	698e6a28276704f8baa082d028db2345b973c4bc
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC INPP5D SH3KBP1 ATP2A3	1.54e-04	191	63	4	96a7179a845d3daa046ed71fa45c51255f130a7f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC INPP5D SH3KBP1 RTN1	1.54e-04	191	63	4	c72e62cf5b45c04ee5e7719db31f917c4f76b1e4
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	UBR1 PTPRC NPIPB5 LYST	1.54e-04	191	63	4	9454f642c3621370fa23640b631301346b300950
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC INPP5D SH3KBP1 ATP2A3	1.54e-04	191	63	4	1a2d5fec2bea96da2154b0aed252f1bb35102f6e
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC INPP5D SH3KBP1 RTN1	1.54e-04	191	63	4	8fd6bdc9d2b1c8d364221d7bc68d03921b668ab5
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ACSL1 ADGRG3 PTPRC LYST	1.54e-04	191	63	4	47156e5f1d790707f42f6283104a44b33af613e5
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC INPP5D SH3KBP1 ATP2A3	1.54e-04	191	63	4	326b4541069efedc8ab409f85bb11f77346dda90
ToppCell	COVID-19-kidney-Myeloid\|kidney / Disease (COVID-19 only), tissue and cell type	ACSL1 ADGRG3 PTPRC LYST	1.57e-04	192	63	4	441cd1ec171f643b28e1f6f9c04def629cc7391b
ToppCell	NS-moderate-d_16-33-Myeloid-Neutrophil\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ACSL1 ADGRG3 PTPRC LYST	1.57e-04	192	63	4	545c3990cbe3c04bfd95a0ab7499d2c4af509be1
ToppCell	PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ACSL1 ADGRG3 PTPRC TYMP	1.57e-04	192	63	4	d44f46352bac414b45cc749f7cbdc3a159bd7ae8
ToppCell	Fetal_29-31_weeks-Immune-monocyte-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PTPRC INPP5D TYMP RTN1	1.57e-04	192	63	4	5417f024fcc89eaeab33f4a2c6421d1cfabd681b
ToppCell	LV-08._Macrophage\|LV / Chamber and Cluster_Paper	PTPRC INPP5D TYMP RTN1	1.57e-04	192	63	4	7be12d580aaf2f2f1562203fcad3a44639b8c5a6
ToppCell	NS-critical-d_0-4-Myeloid-Neutrophil\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ACSL1 ADGRG3 PTPRC LYST	1.57e-04	192	63	4	3db74359c30172a51177e00eac1f48f483e15578
ToppCell	moderate-Myeloid-Neutrophil\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ACSL1 ADGRG3 PTPRC LYST	1.57e-04	192	63	4	8105408400dac5dcb0ce62b558433257559c9f09
ToppCell	COVID-19-kidney-Myeloid\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ACSL1 ADGRG3 PTPRC LYST	1.57e-04	192	63	4	0b9d22a222f1201e375f8e55cace9ef939febae4
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ACSL1 ADGRG3 ATP2A3 LYST	1.60e-04	193	63	4	e1855cff9a6bcfda9188b9fdf6c9d698405da990
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLGAP2 DLGAP1 PAK6 RTN1	1.60e-04	193	63	4	be28070c049e7cb68bcd54f582226eb2f5e4bc1c
ToppCell	Children_(3_yrs)-Immune-monocyte-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DLGAP2 PTPRC INPP5D RTN1	1.60e-04	193	63	4	58e1930a1d80ad3729ab9604ac8ebf7308232a3d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC INPP5D SH3KBP1 ATP2A3	1.60e-04	193	63	4	12f1333f11e6c262954ad7912d8fd2962ab06d25
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL1 PTPRC INPP5D RTN1	1.60e-04	193	63	4	bd08555f02db8bc903caacae57e80bb91e2556ce
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLGAP2 DLGAP1 PAK6 RTN1	1.60e-04	193	63	4	0c652ebe22ce5d2927599dd97ef1920547858395
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLGAP2 DLGAP1 PAK6 RTN1	1.60e-04	193	63	4	8689a70a33a7c3823dc647d41ac0160e7c3ae396
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC INPP5D SH3KBP1 RTN1	1.60e-04	193	63	4	f597fefc54327a1ad136e2f66b6e81cc5c761eb7
ToppCell	nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PTPRC NPIPB4 NPIPB3 NPIPB5	1.60e-04	193	63	4	9c9434a3297b85774b4f0ecab6294f44d738e29f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL1 PTPRC INPP5D RTN1	1.60e-04	193	63	4	374d0526a071e973c3f43b4564f78f6933bb67ed
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL1 PTPRC INPP5D RTN1	1.64e-04	194	63	4	96f16bcd393a0d3f8df479b172b5360ae5a1e663
ToppCell	facs-Thymus-nan-3m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRC SMARCA4 ATP2A3 LYST	1.64e-04	194	63	4	f1661f9f2439fca5c1012c693b0744c4e3b90a9b
ToppCell	Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ACSL1 PTPRC INPP5D TYMP	1.64e-04	194	63	4	3043f6230fa723037c8cf7123f611ae847b39fd4
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ACSL1 ADGRG3 TYMP LYST	1.64e-04	194	63	4	e2d0dfb92356fa7ad7008aa8ac4198e2ac5d2495
ToppCell	LA-08._Macrophage\|World / Chamber and Cluster_Paper	PTPRC INPP5D TYMP RTN1	1.64e-04	194	63	4	c1805572bcc11b1cd29083329d7b5911489fb758
ToppCell	facs-Thymus-nan\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRC SMARCA4 ATP2A3 LYST	1.64e-04	194	63	4	cda1b197efb199330ea7ab25a7cee22cae22589d
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC INPP5D SH3KBP1 RTN1	1.64e-04	194	63	4	0866ab6792cee274a71991d5c37a37f574ff446e
ToppCell	facs-Thymus-nan-3m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRC SMARCA4 ATP2A3 LYST	1.64e-04	194	63	4	66c056232ac216780acf4cc8ea325bd8ed1909c9
Drug	ATP-EDC	ATP2A1 ATP2A2 ATP2A3	2.17e-06	10	61	3	CID000195647
Drug	1sqc	ATP2A1 ATP2A2 ATP2A3	2.17e-06	10	61	3	CID000444279
Drug	2,5-dimethylquinone	ATP2A1 ATP2A2 ATP2A3	2.97e-06	11	61	3	CID000008718
Drug	1vyq	ATP2A1 ATP2A2 ATP2A3	3.96e-06	12	61	3	CID004369390
Drug	p-hydroxyhippuric acid	ATP2A1 ATP2A2 ATP2A3	6.52e-06	14	61	3	CID000151012
Drug	NSC239129	ATP2A1 ATP2A2 ATP2A3	8.14e-06	15	61	3	CID000084597
Drug	AC1L88YH	ATP2A1 ATP2A2 ATP2A3	1.21e-05	17	61	3	CID000374551
Drug	Primidone [125-33-7]; Up 200; 18.4uM; MCF7; HT_HG-U133A	KMT2B LMAN1 SFTPB ATP2A3 LYST WDR48	1.41e-05	196	61	6	5323_UP
Drug	Lysergol [602-85-7]; Down 200; 15.8uM; MCF7; HT_HG-U133A	C14orf93 LMAN1 BRD4 SMARCA4 MAP2K5 ARAP1	1.50e-05	198	61	6	3261_DN
Drug	AC1L380G	ATP2A1 ATP2A2 ATP2A3	1.72e-05	19	61	3	CID000084698
Drug	AC1L25Y6	ATP2A1 ATP2A2 ATP2A3	3.12e-05	23	61	3	CID000015465
Drug	lanthanum chloride hydrate	ATP2A1 ATP2A2 ATP2A3	3.12e-05	23	61	3	CID000165791
Drug	EUK-8	ATP2A1 ATP2A2 ATP2A3	4.04e-05	25	61	3	CID000171249
Drug	cyhexatin	ATP2A1 ATP2A2 ATP2A3	4.04e-05	25	61	3	CID005364545
Drug	AC1L9EX5	ACSL1 LYST	4.22e-05	4	61	2	CID000443620
Drug	dodecyl ether	ATP2A1 ATP2A2 ATP2A3	4.55e-05	26	61	3	CID000020667
Drug	fluorescein isothiocyanate	PTPRC ATP2A1 ATP2A2 ATP2A3 LYST	4.66e-05	147	61	5	CID000018730
Drug	octaethylene glycol	ATP2A1 ATP2A2 ATP2A3	6.36e-05	29	61	3	CID000078798
Drug	Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; HL60; HG-U133A	WASL ADGRG3 PTPRC FAM13A ATP2A3	1.01e-04	173	61	5	2007_UP
Drug	fluorescamine	ATP2A1 ATP2A2 ATP2A3	1.13e-04	35	61	3	CID000037927
Drug	RA-V	ATP2A1 ATP2A2 ATP2A3	1.13e-04	35	61	3	CID000476891
Drug	mag-fura-2	ATP2A1 ATP2A2 ATP2A3	1.33e-04	37	61	3	CID000123839
Drug	gramicidin s	ATP2A1 ATP2A2 ATP2A3	1.33e-04	37	61	3	CID000073357
Drug	trimethyl phosphate	ATP2A1 ATP2A2 ATP2A3	1.56e-04	39	61	3	CID000010541
Drug	flufenoxuron	WASL SMARCA4 ATP2A2	1.56e-04	39	61	3	CID000091766
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	C14orf93 MAP2K5 ATP2A2 ARAP1 WDR48	1.56e-04	190	61	5	6998_UP
Drug	Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A	FLII KMT2B SMARCA4 PAK6 CHRNB1	1.68e-04	193	61	5	4322_UP
Drug	carbidine	ATP2A1 ATP2A2 ATP2A3	1.68e-04	40	61	3	CID000065684
Drug	p-nitrophenyl phosphate	GSTZ1 PTPRC ATP2A1 ATP2A2 ATP2A3	1.72e-04	194	61	5	CID000000378
Drug	Sulfaphenazole [526-08-9]; Down 200; 12.8uM; HL60; HT_HG-U133A	FLII LMAN1 INPP5D SEC31B WDR48	1.77e-04	195	61	5	1836_DN
Drug	Harmine hydrochloride [343-27-1]; Up 200; 16uM; MCF7; HT_HG-U133A	SFTPB INPP5D MAP2K5 ATP2A2 ATP2A3	1.77e-04	195	61	5	2750_UP
Drug	Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; PC3; HT_HG-U133A	ACSL1 LMAN1 BRD4 SRPK1 MAP2K5	1.77e-04	195	61	5	4660_DN
Drug	Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; MCF7; HT_HG-U133A	C14orf93 LMAN1 MAP2K5 ATP2A3 ARAP1	1.77e-04	195	61	5	6245_UP
Drug	Clopamide [636-54-4]; Down 200; 11.6uM; HL60; HG-U133A	LMAN1 SMARCA4 MAP2K5 ATP2A3 WDR48	1.77e-04	195	61	5	1605_DN
Drug	Nafronyl oxalate [3200-06-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A	BHLHE41 KMT2B LMAN1 MAP2K5 WDR48	1.77e-04	195	61	5	5287_UP
Drug	Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; HL60; HT_HG-U133A	FLII BRD4 MAP2K5 AHDC1 ARAP1	1.81e-04	196	61	5	2388_DN
Drug	Cefadroxil [50370-12-2]; Up 200; 11uM; HL60; HT_HG-U133A	FLII BRD4 SMARCA4 MAP2K5 ATP2A3	1.81e-04	196	61	5	1323_UP
Drug	Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; MCF7; HT_HG-U133A	KMT2B BRD4 SMARCA4 SRPK1 ARAP1	1.81e-04	196	61	5	2291_DN
Drug	rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A	LMAN1 BRD4 LYST ARAP1 WDR48	1.81e-04	196	61	5	1658_UP
Drug	Trimetazidine dihydrochloride [13171-25-0]; Down 200; 11.8uM; PC3; HT_HG-U133A	C14orf93 SFTPB CHRNB1 ARAP1 WDR48	1.81e-04	196	61	5	5060_DN
Drug	Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; HL60; HT_HG-U133A	FLII C14orf93 KMT2B RBM26 SEC31B	1.85e-04	197	61	5	2554_DN
Drug	LY 294002; Down 200; 0.1uM; HL60; HT_HG-U133A	KMT2B INPP5D SMARCA4 MAP2K5 ARAP1	1.85e-04	197	61	5	1157_DN
Drug	Nabumetone [42924-53-8]; Down 200; 17.6uM; PC3; HT_HG-U133A	ACSL1 LMAN1 MAP2K5 LYST WDR48	1.85e-04	197	61	5	6327_DN
Drug	Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; MCF7; HT_HG-U133A	C14orf93 SFTPB MAP2K5 AHDC1 ARAP1	1.85e-04	197	61	5	3195_DN
Drug	Metyrapone [54-36-4]; Down 200; 17.6uM; PC3; HT_HG-U133A	FLII SMARCA4 PAK6 MAP2K5 ARAP1	1.85e-04	197	61	5	4606_DN
Drug	Napelline [5008-52-6]; Down 200; 11.2uM; HL60; HT_HG-U133A	LMAN1 INPP5D MAP2K5 LYST WDR48	1.85e-04	197	61	5	2522_DN
Drug	Canavanine sulfate monohydrate (L,+) [206996-57-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A	LMAN1 BRD4 PAK6 SEC31B MAP2K5	1.90e-04	198	61	5	4782_UP
Drug	C12E8	ATP2A1 ATP2A2 ATP2A3	1.95e-04	42	61	3	CID000123921
Drug	Dipyrone [5907-38-0]; Down 200; 12uM; HL60; HT_HG-U133A	BHLHE41 GSTZ1 INPP5D ATP2A2 ARAP1	1.99e-04	200	61	5	2175_DN
Drug	Loperamide hydrochloride [34552-83-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A	LMAN1 SFTPB MAP2K5 ATP2A2 ATP2A3	1.99e-04	200	61	5	5632_DN
Drug	cisapride	TYMP ATP2A1 ATP2A2 ATP2A3	2.33e-04	112	61	4	CID000002769
Drug	R 8231	ATP2A1 ATP2A3	2.51e-04	9	61	2	CID003084926
Drug	agelasine B	ATP2A1 ATP2A2 ATP2A3	2.56e-04	46	61	3	CID006439899
Disease	Brody myopathy (implicated_via_orthology)	ATP2A1 ATP2A2 ATP2A3	7.59e-09	3	59	3	DOID:0050692 (implicated_via_orthology)
Disease	heart disease (implicated_via_orthology)	ATP2A1 ATP2A2 ATP2A3	6.09e-05	38	59	3	DOID:114 (implicated_via_orthology)
Disease	Spastic Paraplegia	LYST WDR48	1.40e-04	9	59	2	C0037772
Disease	Colonic Neoplasms	TCF19 BRD4 SH3KBP1 TYMP	2.47e-04	152	59	4	C0009375
Disease	severe acute respiratory syndrome, COVID-19	DLGAP2 DLGAP1 GLDC INPP5D RBM26 LYST	2.67e-04	447	59	6	EFO_0000694, MONDO_0100096
Disease	Malignant tumor of colon	TCF19 BRD4 SH3KBP1 TYMP	2.93e-04	159	59	4	C0007102
Disease	polychlorinated biphenyls measurement	DLGAP1 GLDC MBD5	3.04e-04	65	59	3	EFO_0007042
Disease	rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement	DLGAP1 PTPRC KMT2B ARAP1	3.78e-04	170	59	4	EFO_0000685, EFO_0007791, EFO_0007837
Disease	carotid atherosclerosis	SMARCA4 FMN2	4.63e-04	16	59	2	EFO_0009783
Disease	sphingomyelin 14:0 measurement	PAK6 CHORDC1	5.24e-04	17	59	2	EFO_0010390
Disease	glucose homeostasis measurement, acute insulin response measurement	ATP2A2 ATP2A3	5.89e-04	18	59	2	EFO_0006831, EFO_0006896
Disease	hemoglobin measurement, mean corpuscular hemoglobin	PTPRC TYMP	8.85e-04	22	59	2	EFO_0004509, EFO_0004527
Disease	testosterone measurement	UBR1 FHAD1 DLGAP1 SLC4A1AP NLGN2 CHORDC1 ATP2A1 CHRNB1 ARAP1	9.15e-04	1275	59	9	EFO_0004908
Disease	Streptozotocin Diabetes	ACSL1 ATP2A2 ATP2A3	1.34e-03	108	59	3	C0038433
Disease	Diabetes Mellitus, Experimental	ACSL1 ATP2A2 ATP2A3	1.34e-03	108	59	3	C0011853
Disease	Alloxan Diabetes	ACSL1 ATP2A2 ATP2A3	1.34e-03	108	59	3	C0002152

Protein segments in the cluster

Peptide	Gene	Start	Entry
APRMDTPPPEERLEK	CCDC89	11	Q8N998
SDQDDRRMKKEPPPL	CFAP77	186	Q6ZQR2
LPQRPEMKPVDVGRP	BRD4	1146	O60885
KQEPPGEDSPAPKRM	BHLHE41	266	Q9C0J9
MEDLGRANRRKPKPP	ACSL1	251	P33121
KRPKPERDLMPEPPH	CHRNB1	361	P11230
VPRQVMKDEDKPPDR	ADGRG3	116	Q86Y34
MKDEDKPPDRVRLPK	ADGRG3	121	Q86Y34
QMDPLDKKERRAPPP	DLGAP1	901	O14490
MESPERKEERKVPPP	DLGAP2	976	Q9P1A6
TPKADKEPLEMARPP	AHDC1	1511	Q5TGY3
PPDLDIMDRPPRSPK	ATP2A1	811	O14983
PPDLDIMEKLPRSPR	ATP2A3	811	Q93084
RKPKRQRAAEMEPPP	NPIPB3	941	Q92617
QRAAEMEPPPEPKRR	NPIPB3	946	Q92617
MEPPPEPKRRRVGDV	NPIPB3	951	Q92617
DMDLPPREKPPNKSS	RBM26	466	Q5T8P6
PKRQRAAEMEPPPEP	NPIPB12	821	F8W0I5
PVQAMKRLRDSPPPK	PAK6	606	Q9NQU5
RENPNLVMPPKPADR	FLII	371	Q13045
DPPKPERKGPEMPRL	LMTK3	1196	Q96Q04
ENKPERPSGRKPRPM	DCLK3	331	Q9C098
RKQPKERPAPEELMG	MAP2K5	401	Q13163
RNMPSNEKPKCPELP	LMAN1	456	P49257
GAPKRMPPKEALERE	MYCLP1	221	P12525
PKRQRAAEMEPPPEP	NPIPB5	1026	A8MRT5
KTPRRFMDEDPPKPP	KMT2B	541	Q9UMN6
PKRQRAAEMEPPPEP	NPIPB4	1031	C9JG80
TRGLERDMPKPPPKT	FAM13A	266	O94988
RKPKRQRAAEMEPPP	NPIPB11	1081	E5RHQ5
QRAAEMEPPPEPKRR	NPIPB11	1086	E5RHQ5
MEPPPEPKRRRVGDV	NPIPB11	1091	E5RHQ5
PDLDIMNKPPRNPKE	ATP2A2	811	P16615
APKEERPQDPLVAPM	FHAD1	966	B1AJZ9
ENGTKLPPPRPEDML	C14orf93	241	Q9H972
RKGAREDDPMPPVQP	LYST	3216	Q99698
EMRPTPRLLPQDPKK	GSTZ1	81	O43708
PQGDRQMRPPKPKRR	MBD5	1476	Q9P267
GSRKQPIEPCRPMKP	FMN2	1281	Q9NZ56
PPDTDIRDPGKKPVM	NLGN2	166	Q8NFZ4
QEKVRLGLMPPPEPK	PRPF3	461	O43395
PKRQRAAEMEPPPEP	NPIPB13	1031	A6NJU9
DEIMKIETPAPRKPP	RTKN	426	Q9BST9
PKREQDSPPMKPSAL	RTN1	481	Q16799
MPPRKKRRQPSQKAP	RHNO1	1	Q9BSD3
PLPKGQMSREKQPDP	TGIF2LX	161	Q8IUE1
EQEPGMSDPLPKPLR	SFTPB	151	P07988
KRPPKRTPDMIQQPR	TDRD10	106	Q5VZ19
TEPEMEPNPKSRPRA	SLC26A8	906	Q96RN1
IKKIPPERPEMLPNR	SH3KBP1	361	Q96B97
PKRKPRLMEEDELPS	SMARCA4	1331	P51532
PAPRKDQESPKMPRK	INPP5D	1031	Q92835
KRGRPMTKNLDPDPE	SPINDOC	231	Q9BUA3
LPPEKMERKELPPEH	SEC31B	1061	Q9NQW1
SPVERPLKENPPNKM	SRPK1	311	Q96SB4
MTKKEEPPPSRVPRA	ARAP1	246	Q96P48
KPVEAIKRPSPDEPM	CHORDC1	101	Q9UHD1
PENPPPVLMEPRKKL	TCF19	241	Q9Y242
PVLKMELDRSADPPP	WDR48	296	Q8TAF3
DHPAMAEPLPEPKKR	SYNGAP1	1276	Q96PV0
LKVPPDERDPRVPML	UBR1	1306	Q8IWV7
EPLQKMPEGRVPPER	ZNF827	706	Q17R98
APKESEEPRKMRSPP	ZNF496	11	Q96IT1
EKRRDPPNGPNLPMA	WASL	146	O00401
NMKKRDPPSEPSPLE	PTPRC	931	P08575
PEPKQLPELIRMKRD	TYMP	31	P19971
PANIRLKRPLKMEDP	GLDC	96	P23378
RPELPPTLMRMKDEP	SLC4A1AP	631	Q9BWU0